Lyell Immunopharma Inc. (LYEL)
NASDAQ: LYEL
· Real-Time Price · USD
10.62
-0.14 (-1.30%)
At close: Aug 15, 2025, 3:59 PM
10.58
-0.38%
After-hours: Aug 15, 2025, 04:10 PM EDT
Lyell Immunopharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 8K | 7K | 11K | 34K | 13K | 3K | 13K | 25K | 27K | 65K | 48.39K | 3K | 35.74M | 553K | 2.82M | 2.75M | 2.63M | 2.44M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 5.06M | 5.1M | 4.54M | 5.03M | 4.59M | 4.17M | 3.73M | 3.97M | 3.99M | n/a | n/a | 3M |
Gross Profit | 8K | 7K | 11K | 34K | 13K | 3K | -5.04M | -5.08M | -4.51M | -4.96M | -4.54M | -4.17M | 32.01M | -3.42M | -1.17M | 2.75M | 2.63M | -553K |
Operating Income | -47.14M | -57.37M | -201.15M | -50.51M | -51.53M | -55.58M | -59.51M | -59.04M | -65.91M | -62.56M | -8.4K | -66.44M | -37.26M | -68.58M | -47.54M | -49.16M | -62.71M | -55.37M |
Interest Income | 3.28M | 3.86M | 4.92M | 5.96M | 6.36M | 6.82M | 7.08M | 6.61M | 5.26M | 4.5M | 3.45M | 2.25M | 952K | 397K | 323K | 270K | 218K | 354K |
Pretax Income | -42.68M | -52.2M | -191.94M | -44.58M | -45.81M | -60.67M | -52.93M | -50.85M | -63.89M | -66.96M | -8.4K | -70.25M | -36.32M | -68.14M | -83.71M | -48.88M | -62.59M | -55.04M |
Net Income | -42.68M | -52.2M | -191.94M | -44.58M | -45.81M | -60.67M | -52.93M | -50.85M | -63.89M | -132.63M | 2.44M | -74.07M | -36.32M | -67.71M | -83.71M | -48.88M | -62.59M | -55.04M |
Selling & General & Admin | 9.79M | 14.05M | 14.52M | 11.77M | 12.26M | 13.49M | 13.17M | 15.51M | 19.03M | 19.28M | 26.35K | 26.08M | 30.45M | 34.42M | 31.87M | 21.24M | 19.11M | 16.83M |
Research & Development | 34.86M | 43.45M | 48.67M | 39.5M | 40.26M | 43.17M | 41.62M | 43.85M | 47.47M | 44.63M | 38.03K | 41.61M | 43.72M | 35.83M | 19.29M | 31.43M | 46.45M | 41.53M |
Other Expenses | 2.5M | -119K | 137.97M | -730K | -976K | -1.09M | -506K | 1.58M | -326K | -1.29M | 3.54K | -1.25M | -14K | -1.12M | -44K | 16K | -106K | -27K |
Operating Expenses | 47.15M | 57.37M | 201.16M | 50.54M | 51.54M | 55.58M | 54.79M | 59.06M | 65.93M | 62.62M | 67.92K | 66.44M | 73M | 69.13M | 50.36M | 51.92M | 65.33M | 57.81M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 47.15M | 57.37M | 201.16M | 50.54M | 51.54M | 55.58M | 59.84M | 59.06M | 65.93M | 62.62M | 67.92K | 66.44M | 73M | 69.13M | 50.36M | 51.92M | 65.33M | 57.81M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 65.67M | -2.45M | 3.82M | n/a | -432K | -323K | -270K | -218K | -354K |
Shares Outstanding (Basic) | 14.79M | 295.1M | 266.54M | 256.31M | 255.4M | 254.25M | 253.09M | 251.32M | 250.2M | 249.59M | 249.57M | 248.32M | 246.31M | 244.18M | 242.74M | 239.79M | 238.55M | 246.58M |
Shares Outstanding (Diluted) | 14.79M | 295.1M | 266.54M | 256.31M | 255.4M | 254.25M | 253.09M | 251.32M | 250.2M | 249.59M | 249.57M | 248.32M | 246.31M | 244.18M | 242.74M | 239.79M | 238.55M | 246.58M |
EPS (Basic) | -2.89 | -0.18 | -0.72 | -0.17 | -0.18 | -0.24 | -0.21 | -0.2 | -0.26 | -0.27 | -0.03 | -0.28 | -0.15 | -0.28 | -0.34 | -0.2 | -0.26 | -0.22 |
EPS (Diluted) | -2.89 | -0.18 | -0.72 | -0.17 | -0.18 | -0.24 | -0.21 | -0.2 | -0.26 | -0.27 | -0.03 | -0.28 | -0.15 | -0.28 | -0.34 | -0.2 | -0.26 | -0.22 |
EBITDA | -42.56M | -53.93M | -57.64M | -45.83M | -46.63M | -50.55M | -54.45M | -53.94M | -60.84M | -57.53M | -9.74M | -61.82M | -33.09M | -64.17M | -42M | -45.07M | -59.7M | -53.41M |
EBIT | -45.7M | -57.37M | -62.67M | -50.51M | -51.53M | -55.58M | -59.51M | -59.04M | -65.91M | -62.56M | -8.4M | -66.44M | -37.26M | -68.58M | -47.54M | -49.16M | -62.71M | -55.37M |
Depreciation & Amortization | 3.13M | 3.44M | 5.03M | 4.68M | 4.9M | 5.02M | 5.06M | 5.1M | 5.06M | 5.03M | 4.59M | 4.17M | 3.73M | 3.97M | 3.99M | 4.09M | 3.86M | 3M |